Citadel Advisors - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$43,709,757
-27.8%
2,178,951
+1.6%
0.01%
-25.0%
Q2 2023$60,499,053
+161.6%
2,144,596
+59.5%
0.01%
+140.0%
Q1 2023$23,128,719
+73.0%
1,344,693
+102.6%
0.01%
+66.7%
Q4 2022$13,369,335
+2.2%
663,820
+9.9%
0.00%0.0%
Q3 2022$13,082,000
-40.5%
604,001
-22.8%
0.00%
-40.0%
Q2 2022$21,997,000
-10.7%
782,795
+46.6%
0.01%0.0%
Q1 2022$24,635,000
-52.7%
533,925
-13.9%
0.01%
-50.0%
Q4 2021$52,120,000
-30.3%
620,036
-44.7%
0.01%
-33.3%
Q3 2021$74,763,000
+12.7%
1,121,893
-10.1%
0.02%0.0%
Q2 2021$66,360,000
+44.9%
1,247,380
+18.2%
0.02%
+36.4%
Q1 2021$45,794,000
-41.4%
1,055,389
-29.8%
0.01%
-45.0%
Q4 2020$78,112,000
+41.4%
1,503,870
-11.0%
0.02%
+25.0%
Q3 2020$55,234,000
-26.3%
1,689,634
+8.3%
0.02%
-40.7%
Q2 2020$74,944,0001,560,6870.03%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 2,099,583$42,117,63514.06%
Mayo Clinic 187,143$3,754,0897.23%
Matrix Capital Management Company, LP 13,959,973$280,037,0583.36%
5AM Venture Management, LLC 490,000$9,829,4002.83%
Eventide Asset Management 7,814,039$156,749,6222.82%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 961,486$19,287,4102.70%
Avidity Partners Management LP 2,100,000$42,126,0001.70%
First Light Asset Management, LLC 848,477$17,020,4491.62%
Sofinnova Investments, Inc. 1,211,641$24,305,5181.53%
SECTORAL ASSET MANAGEMENT INC 386,525$7,753,6921.51%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders